Incyte Pharmaceuticals, Inc.
Records under this name other than patents Incyte Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Incyte Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,051,692 | Human retinoid binding protein Term ended Term ended Jan 22, 2019 · USPTO record | Term ended | Term ended Jan 22, 2019 | USPTO record |
| US 6,143,870 | Thrombin receptor homolog Term ended Term ended Dec 21, 2018 · USPTO record | Term ended | Term ended Dec 21, 2018 | USPTO record |
| US 6,235,880 | Human sulfonylurea receptor Term ended Term ended Dec 9, 2018 · USPTO record | Term ended | Term ended Dec 9, 2018 | USPTO record |
| US 6,071,701 | Method of detection for a polynucleotide encoding chemokine expressed in inflamed adenoid Term ended Term ended Dec 1, 2018 · USPTO record | Term ended | Term ended Dec 1, 2018 | USPTO record |
| US 6,019,966 | Human JAK2 kinase Term ended Term ended Nov 19, 2018 · USPTO record | Term ended | Term ended Nov 19, 2018 | USPTO record |
| US 6,063,579 | Alignment mechanism Formerly held Term ended Term ended Oct 30, 2018 · USPTO record | Term ended | Term ended Oct 30, 2018 | USPTO record |
| US 6,060,250 | Human transferases Term ended Term ended Jun 30, 2018 · USPTO record | Term ended | Term ended Jun 30, 2018 | USPTO record |
| US 6,143,867 | Human eosinophil-derived basic protein Term ended Term ended Mar 17, 2018 · USPTO record | Term ended | Term ended Mar 17, 2018 | USPTO record |
| US 6,075,136 | Prostate-associated serine protease Term ended Term ended Feb 17, 2018 · USPTO record | Term ended | Term ended Feb 17, 2018 | USPTO record |
| US 6,203,979 | Human protease molecules Term ended Term ended Jan 16, 2018 · USPTO record | Term ended | Term ended Jan 16, 2018 | USPTO record |